Ablation of NR2F6 enhances the expression of interleukin-2 (IL-2), interferon -γ (IFN-γ), and tumor necrosis factor-α (TNF-α) secretion, thereby promoting anti-tumor immune responses. Here, NR2F6 is linked to neoplasm.